A retrospective, multicenter, observational cohort study of antiviral activity of rilpivirine/emtricitabine/tenofovir disoproxil fumarate and pharmacokinetics of rilpivirine
Latest Information Update: 13 May 2020
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
Most Recent Events
- 13 May 2020 New trial record
- 06 May 2020 Results published in the British Journal of Clinical Pharmacology